Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Treatment
Share your love
Azalea’s First On-Eye Test of ALMA Smart Contact Lens
Azalea Vision announced the successful demonstration of the ALMA Lens, marking the debut of the first functional prototype for the Azalea smart contact lens platform. The ALMA proprietary device is designed to provide a non-surgical solution for individuals dealing with…
Connection between Keratoconus and DED
Dry eye disease is more common in people over the age of 50. Hormonal changes, especially common in women, can cause dry eye. Other medical conditions including diabetes, glaucoma, Sjogren’s syndrome, lupus, and rheumatoid arthritis can exacerbate dry eye symptoms.…
The Silent Thief of Sight: What is Glaucoma?
Imagine you wake up one morning, and everything seems a little blurry. At first, you think it’s just a sleepy haze, but your vision doesn’t clear up as the day goes on. You visit the eye doctor, and after a…
How Antioxidants Stand Guard for Healthy Eyes
Our eyes are intricate organs that are exposed to various environmental factors and oxidative stress throughout our lives. The presence of highly reactive molecules called free radicals can damage the cells and tissues in our eyes, leading to vision problems…
Australian Government Allocates $35M for Blindness Research
In a significant stride towards combating global corneal blindness, the Australian Government’s Medical Research Futures Fund (MRFF) has allocated a substantial sum of $35 million to BIENCO, a consortium comprising clinical, scientific, and governance experts. The University of Wollongong (UOW)…
Irvine-Gass Syndrome: Causes, Symptoms, and Treatment
What Is Irvine–Gass Syndrome? Irvine–Gass Syndrome, also known as cystoid macular edema (CME), is a notable complication that can occur after cataract surgery. It is characterized by the accumulation of fluid in the macula, the central region of the retina…
Roche Halts Development of Diabetic Retinopathy Drug
Swiss-based pharmaceutical company Roche has announced the discontinuation of its oral diabetic retinopathy treatment, vicasinabin, after successfully completing Phase II clinical trials. In a recent presentation to investors, Roche confirmed its decision to halt further investment in vicasinabin, a promising…
EyePoint Launches VERONA Trial for EYP-1901 in DME
EyePoint Pharmaceuticals announced the dosing of the first patient in the VERONA clinical trial for their investigational therapy, EYP-1901, for the treatment of Diabetic Macular Edema (DME). EYP-1901, a sustained delivery therapy, incorporates vorolanib, a selective tyrosine kinase inhibitor, formulated…
Roth Spots: Causes, Symptoms and Management
Roth spots are retinal hemorrhages with white or pale centers. They are named after Moritz Roth, who first described them in the late 19th century. In medical terms, Roth spots represent a significant clinical finding as they may indicate an…
What is Hypertensive Retinopathy and How to Manage it
Hypertensive retinopathy is a condition that affects the blood vessels in the eyes and is directly linked to uncontrolled high blood pressure. This condition is a critical example of how hypertension can impact various organs, including the eyes. In this…